Structure

InChI Key PEJHHXHHNGORMP-UHFFFAOYSA-M
Smile OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2.[Br-]
InChI
InChI=1S/C29H34NO2.BrH/c31-29(26-12-6-2-7-13-26,27-14-8-3-9-15-27)28-16-19-30(20-17-28,21-18-28)22-23-32-24-25-10-4-1-5-11-25;/h1-15,31H,16-24H2;1H/q+1;/p-1

Physicochemical Descriptors

Property Name Value
Molecular Formula C29H34BrNO2
Molecular Weight 508.5
AlogP 5.14
Hydrogen Bond Acceptor 2.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 8.0
Polar Surface Area 29.46
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 32.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Muscarinic acetylcholine receptor M3 antagonist FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Asthma 3 D001249 ClinicalTrials

Related Entries

Scaffolds

Parent
Mixture
Mixture

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Respiratory, thoracic and mediastinal disorders
18.41
Injury, poisoning and procedural complications
16.52
General disorders and administration site conditions
11.3
Gastrointestinal disorders
8.51
Cardiac disorders
7.98
Nervous system disorders
7.09
Eye disorders
3.44
Psychiatric disorders
3.17
Infections and infestations
2.9
Skin and subcutaneous tissue disorders
2.86
Product issues
2.78
Musculoskeletal and connective tissue disorders
2.61
Vascular disorders
2.27
Renal and urinary disorders
2.18
Immune system disorders
2.13

Cross References

Resources Reference
ChEMBL CHEMBL523299
EPA CompTox DTXSID50235966
FDA SRS 7AN603V4JV
PubChem 11519069
SureChEMBL SCHEMBL109931